跳至主要内容
临床试验/NCT00570219
NCT00570219已完成不适用

The Effect of Valproate Treatment on Withdrawal Severity in Benzodiazepine Dependent Opioid Maintenance Treatment Patients

University of Helsinki1 个研究点 分布在 1 个国家目标入组 30 人开始时间: 2005年2月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
状态
已完成
入组人数
30
试验地点
1
主要终点
benzodiazepine withdrawal severity

研究概览

简要总结

The aim of this study is to determine whether valproate is effective in the treatment of benzodiazepine withdrawal symptoms in subjects receiving maintenance treatment for opiate dependence.

详细描述

In Finland, 90% of subjects with opioid dependence are dependent on benzodiazepines too. Concurrent use of opioids and benzodiazepines has increasingly caused deaths.

Benzodiazepine withdrawal treatment usually comprises gradual drug discontinuation. In one study, valproate was shown to improve benzodiazepine discontinuation success in chronic benzodiazepine users. In the present study, the effectiveness of gradual benzodiazepine discontinuation combined with valproate treatment and carried out in an inpatient setting is compared with gradual discontinuation without pharmacological augmentation.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Single (Outcomes Assessor)

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者
否

入选标准

  • •Diagnosis of benzodiazepine dependence (DSM IV-R)
  • •Induction of buprenorphine or methadon maintenance treatment, or need of benzodiazepine withdrawal treatment during ongoing buprenorphine/methadon maintenance

排除标准

  • •Pregnancy
  • •History of convulsions
  • •Unstable somatic diseases

研究组 & 干预措施

B

Experimental

Gradual benzodiazepine discontinuation and valproate treatment

干预措施: valproate (Drug)

结局指标

主要结局

benzodiazepine withdrawal severity

时间窗: 3 weeks

次要结局

  • benzodiazepine use(4 weeks after treatment)
  • attrition from treatment(3 weeks)

研究者

申办方类型
Other

研究点 (1)

Loading locations...

相似试验